Table 4.
Univariate and Multivariate Analyses for Predictors of Severe COVID‐19 in Patients With AIH
| Univariate Analysis | Multivariate Analysis | |||||
|---|---|---|---|---|---|---|
| OR | 95% CI | P | OR | 95% CI | P | |
| Sex (female) | 1.19 | 0.31‐4.59 | 0.792 | 2.20 | 0.44‐10.82 | 0.330 |
| Age (>65 years) | 2.81 | 0.84‐9.40 | 0.093 | 1.03 | 0.23‐4.48 | 0.964 |
| Overlap of PBC/PSC | 1.31 | 0.33‐5.23 | 0.694 | |||
| Extrahepatic autoimmune diseases | 1.26 | 0.40‐3.98 | 0.684 | |||
| BMI (>30) | 1.94 | 0.44‐8.54 | 0.378 | |||
| Comorbidities | 6.46 | 1.73‐24.02 | 0.005 | 4.16 | 0.94‐18.36 | 0.060 |
| Prednisolone (≥10 mg) | 2.12 | 0.70‐6.48 | 0.192 | |||
| Complete response to therapy | 0.53 | 0.16‐1.72 | 0.297 | |||
| Cirrhosis | 19.44 | 5.04‐74.92 | <0.001 | 17.46 | 4.22‐72.13 | <0.001 |
| Immunosuppression maintenance | 0.82 | 0.28‐2.36 | 0.718 | |||
| Acute liver injury | 1.67 | 0.57‐4.86 | 0.346 | |||
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.